Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
10(29%)
Results Posted
0%(0 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_3
2
6%
Ph not_applicable
18
53%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution20 total trials
Phase 3Large-scale testing
2(10.0%)
N/ANon-phased studies
18(90.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

10

trials recruiting

Total Trials

34

all time

Status Distribution
Active(13)
Completed(10)
Terminated(2)
Other(9)

Detailed Status

Completed10
unknown9
Recruiting9
Not yet recruiting3
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
34
Active
10
Success Rate
90.9%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (10.0%)
N/A18 (90.0%)

Trials by Status

active_not_recruiting13%
completed1029%
unknown926%
withdrawn13%
not_yet_recruiting39%
recruiting926%
terminated13%

Recent Activity

Clinical Trials (34)

Showing 20 of 34 trialsScroll for more
NCT06159634Not Applicable

Traction vs. No Traction in Colonic ESD

Recruiting
NCT04919824Not Applicable

Monopolar Current Cutting Knife vs Bipolar RFA Knife

Active Not Recruiting
NCT06134687Not Applicable

Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection

Recruiting
NCT07410767

Advanced Endoscopic Resections for Rectal Neoplasms

Not Yet Recruiting
NCT05468008

Endoscopic Submucosal Dissection (ESD)

Recruiting
NCT07373015Not Applicable

Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm

Not Yet Recruiting
NCT04592003

French Colorectal ESD Cohort in Experts Centers

Recruiting
NCT02989818

Multi-center Evaluation of the Clinical Utility of ESD in the Western Population

Recruiting
NCT03039309

Endoscopic Submucosal Dissection for Early GI Neoplasia in the United Kingdom

Recruiting
NCT04032119Phase 3

RCT of Gastric ESD With or Without Epineprhine Added Solution

Completed
NCT02198729Not Applicable

Comparison Rectal Endoscopic Submucosal Dissection to Endoscopic Mucosal Resection

Completed
NCT04008407Not Applicable

ESD for Colorectal LSL Using a Selective Strategy - a Prospective Cohort Study

Recruiting
NCT05930860

Efficacy and Safety of ESD for the Treatment of Superficial Gastric Neoplasms

Recruiting
NCT04890171Not Applicable

Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type

Recruiting
NCT06121752Not Applicable

Device Assisted Full Thickness Resection Versus Endoscopic Submucosal Dissection for Duodenal Neuroendocrine Tumors

Unknown
NCT05736705Not Applicable

Monopolar and Bipolar in Esophageal ESD

Withdrawn
NCT04977401Not Applicable

EndoscoPic Submucosal dIssection Using geL Versus glycerOl for Submucosal iNjection

Terminated
NCT06060106

Endoscopic Submucosal Dissection Versus Esophagectomy for Early Esophageal Carcinoma

Completed
NCT03427346Not Applicable

Neoplastic Barrett Esophagus: Endoscopic Piecemeal vs. En Bloc Resection

Unknown
NCT05728710

Outcomes of Perforation After Colorectal Endoscopic Submucosal Dissection

Unknown

Drug Details

Intervention Type
PROCEDURE
Total Trials
34